Anzeige
Mehr »
Login
Sonntag, 22.12.2024 Börsentäglich über 12.000 News von 679 internationalen Medien
Breaking News: Vorweihnachtlicher Kaufrausch an der Börse?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3C87U | ISIN: CA90468F1027 | Ticker-Symbol: L7T
Tradegate
20.12.24
21:56 Uhr
0,310 Euro
0,000
0,00 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
UNIDOC HEALTH CORP Chart 1 Jahr
5-Tage-Chart
UNIDOC HEALTH CORP 5-Tage-Chart
RealtimeGeldBriefZeit
0,3040,31621.12.
0,0000,00020.12.
ACCESSWIRE
657 Leser
Artikel bewerten:
(2)

UniDoc Health Corp.: UniDoc Ships First AI-Equipped H3 Health Cubes to Commercial Customers

Finanznachrichten News

Three Shipments Mark Progress in eHealth Deployment

VANCOUVER, BC / ACCESSWIRE / November 6, 2024 / UniDoc Health Corp. (CSE:UDOC)(FRA:L7T)(OTCQB:UDOCF) ("UniDoc," or the "Company"), an innovator in the eHealth sector, is pleased to announce the initial shipment of its first AI-assisted H3 Health Cubes, for three commercial orders. These orders include units for the Aiutamoli a Vivere Foundation in Italy, the Municipality of Aliano, and Hope Ukraine Foundation - Ukraine's largest children's hospital, Okhmatdyt. This milestone marks a significant step in UniDoc's transition from development to commercialization.

Key Features:

  • UniDoc ships H3 Health Cubes for three orders, marking an expansion in delivering eHealth services.

  • Shipments include units for the Aiutamoli a Vivere Foundation, the Municipality of Aliano, and Okhmatdyt Children's Hospital.

  • Clients plan to deploy these cubes before the end of the year, providing immediate patient access in underserved areas.

Tony Baldassarre, CEO of UniDoc, stated, "We are extremely proud and excited to fulfill these initial orders, which represent a milestone step forward for UniDoc as we transition to a revenue generating business. These deployments not only enhance healthcare accessibility in critical regions but also build a strong foundation for the many growth opportunities that we see ahead of us."

The first shipment includes the first of three H3 Health Cubes to be supplied to the Italian aid group Aiutamoli a Vivere Foundation ("AVF"). AVF has indicated further plans to potentially expand to up to fifteen units. These cubes will be deployed in conflict-affected regions at the discretion of AVF, including Ukraine and the Gaza Strip, where they will provide essential healthcare services through advanced AI technology and telemedicine capabilities. AVF will manage the deployment and operation of these units, bringing much-needed healthcare support to these areas.

The second shipment is for the Municipality of Aliano, which includes a single H3 Health Cube that will be installed at the Territorial Health Center, enhancing rural healthcare access to small communities in a region where the nearest hospitals are over 100 kilometers away. This unit will deliver essential healthcare services locally, reducing the need for long-distance travel and providing continuous health monitoring and remote consultations.

Through UniDoc's partnership with HP Inc., the third shipment will be the deployment of an H3 Health Cube to Okhmatdyt, Ukraine's largest children's hospital. This deployment, facilitated by the Hope Ukraine Foundation, addresses the urgent need for healthcare services following a recent missile attack. The AI-equipped H3 Health Cube will enhance medical care accessibility and precision, particularly in pediatric care. This shipment represents the first of 10 initial cubes ordered by HP Inc.

All three units have completed the final stages of fabrication and have now shipped. Clients are planning to deploy these units immediately upon receipt, ensuring that patients in need will have access to critical healthcare services as soon as possible.

This fulfillment of multiple orders marks a significant achievement for UniDoc as the Company continues to gain momentum in the eHealth market. With these successful shipments, UniDoc is working to expand its reach and impact, leveraging its innovative technology to improve healthcare access worldwide.

On Behalf of the Board of Directors,

~Antonio Baldassarre~

Antonio Baldassarre
CEO, President & Director
UniDoc Health Corp.

About UniDoc Health Corp. (CSE:UDOC)(FRA:L7T)(OTCQB:UDOCF)
UniDoc is developing an eHealth solution which is being designed as a self-contained remote virtual clinic within a private kiosk for patients to undergo full consultations as if they were present in a physician's office. eHealth opens the doors to a large segment of the population challenged by access, experience or understanding of online computer technology. It is the Company's belief that physical accessibility is the key to its business proposition. UniDoc is dedicated to unlocking shareholder value by delivering an excellent product and sophisticated commercial network within an expedited timeframe. The UniDoc team encourages engagement, questions, and interest, so please stay in touch and invite anyone who might be interested in our story to visit our website at www.unidoctor.com and signup to receive the latest information with updates on our activities, events and progress.

For further information, please contact:
UniDoc Investor Relations
Tel: +1 778.383.6731
Email: info@unidoctor.com

Matt Chatterton, Director
Tel: +1 778.613.2082
Email: matt@unidoctor.com

Media Inquiries media@unidoctor.com

Forward-Looking Statements
This news release contains statements and information that, to the extent that they are not historical fact, may constitute "forward-looking information" within the meaning of applicable securities legislation. Forward-looking information may include financial and other projections, as well as statements regarding future plans, objectives, or economic performance, or the assumption underlying any of the foregoing. In some cases, forward-looking statements can be identified by terms such as "may", "would", "could", "will", "will be", "likely", "except", "anticipate", "believe", "intend", "plan", "forecast", "project", "estimate", "outlook", or the negative thereof or other similar expressions concerning matters that are not historical facts. Examples of such statements include, but are not limited to, statements with respect to the receipt and timing of revenue from the deployment of the Company's first three H3 Health Cubes, the timing of the deployment of the H3 Health Cubes by the client recipients, the fulfillment of outstanding purchase orders by the Company, and the benefits to be realized by the deployment of the H3 Health Cubes.

Forward-looking information is based on the assumptions, estimates, analysis, and opinions of management made in light of its experience and its perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances at the date that such statements are made, but which may prove to be incorrect. The material factors and assumptions used to develop the forward-looking information contained in this news release include, but are not limited to, key personnel and qualified employees continuing their involvement with the Company; the Company's ability to secure additional financing on reasonable terms; the competitive conditions of the industries in which the Company operates; and laws and any amendments thereto applicable to the Company.

Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from any future results, performance or achievements expressed or implied by the forward-looking information, including, without limitation, risks relating to the future business plans of the Company; risks that the Company will not be able to retain its key personnel; risks that the Company will not be able to secure financing on reasonable terms or at all; as well as all of the other risks as described in the Company's annual management discussion and analysis dated July 31, 2024 under the heading "Risks Factors." Accordingly, readers should not place undue reliance on any such forward-looking information.

Further, any forward-looking information speaks only as of the date on which such statement is made. New factors emerge from time to time, and it is not possible for the Company's management to predict all such factors and to assess in advance the impact of each such factor on the Company's business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking information. The Company does not undertake any obligation to update any forward-looking information to reflect information or events after the date on which it is made or to reflect the occurrence of unanticipated events, except as required by law, including securities laws.

The CSE does not accept responsibility for the adequacy or accuracy of this release.

SOURCE: UniDoc Health Corp.



View the original press release on accesswire.com

© 2024 ACCESSWIRE
6 Richtige für 2025
Das Börsenjahr 2025 klopft schon an die Tür – und wie immer geht es um die Frage: Welche Aktien werden die großen Gewinner sein? Die Auswahl an Möglichkeiten ist riesig, doch nur ein paar echte Volltreffer stechen heraus.

Ob stabiler Dividenden-Lieferant, Tech-Pionier oder spekulative Wette im Krypto-Bereich – wir haben die Märkte für Sie ausgiebig durchforstet und präsentieren Ihnen 6 Unternehmen, die große Chancen auf außergewöhnliche Kurssteigerungen besitzen. Hier sind, speziell für Sie, Ihre „6 Richtigen“ für 2025.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche Unternehmen das Potenzial besitzen, im kommenden Jahr richtig durchzustarten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.